Medicare Enrolled
Dr. Eric Harris, D.O.
Hematology · Daytona Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harris
Dr. Eric Harris is a hematology specialist in Daytona Beach, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Harris performed 87,698 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Harris received a total of $150,121 from 85 pharmaceutical and/or device companies across 879 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harris is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 49% volume in FL
$150,121 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 12441 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗87,698
Medicare services
Top 49% in FL for hematology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 27,400 | $43 | $137 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
20,250 | $1 | $3 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,790 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,400 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $19 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,044 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,322 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,102 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 800 | $0 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
614 | $64 | $239 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
547 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
524 | $96 | $378 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
451 | $2 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
434 | $95 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
359 | $10 | $69 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
170 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
137 | $48 | $178 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
116 | $47 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
116 | $7 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
114 | $22 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
104 | $1 | $6 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
102 | $62 | $197 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
97 | $3 | $11 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
84 | $136 | $556 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
75 | $28 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $79 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
65 | $2 | $8 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
59 | $24 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $134 | $562 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
45 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 43 | $167 | $585 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
41 | $42 | $170 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
38 | $25 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $15 | $56 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $7 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $94 | $285 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
19 | $1 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $115 | $453 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $41 | $147 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $140 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
41.1% high complexity
54.3% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$150,121
Total received (2018-2024)
Avg $21,446/year across 7 years
Top 3% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
879
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,664
2023
$2,886
2022
$8,656
2021
$22,820
2020
$13,712
2019
$42,932
2018
$56,451
Payments by company (2024)
PFIZER INC.
$229
Novartis Pharmaceuticals Corporation
$229
Merck Sharp & Dohme LLC
$222
Celgene Corporation
$183
Gilead Sciences, Inc.
$131
Eisai Inc.
$116
Janssen Biotech, Inc.
$115
Daiichi Sankyo Inc.
$103
AstraZeneca Pharmaceuticals LP
$96
Genentech USA, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$70
Incyte Corporation
$67
EMD Serono, Inc.
$65
Astellas Pharma US Inc
$60
GENZYME CORPORATION
$59
Lilly USA, LLC
$59
Pharmacosmos Therapeutics Inc.
$57
TAIHO ONCOLOGY, INC.
$46
E.R. Squibb & Sons, L.L.C.
$46
Mirati Therapeutics, Inc.
$45
TerSera Therapeutics LLC
$44
JAZZ PHARMACEUTICALS INC.
$40
Exelixis Inc.
$40
PharmaEssentia USA Corporation
$38
ARRAY BIOPHARMA INC
$37
Janssen Pharmaceuticals, Inc
$35
Takeda Pharmaceuticals U.S.A., Inc.
$32
Stemline Therapeutics Inc.
$29
BeiGene USA, Inc.
$29
GlaxoSmithKline, LLC.
$28
Alnylam Pharmaceuticals Inc.
$27
Aveo Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
ABBVIE INC.
$23
CSL Behring
$22
Kite Pharma, Inc.
$21
Coherus Biosciences Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Abbott Laboratories
$16
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 25.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$71,799
E.R. Squibb & Sons, L.L.C.
$41,726
Gilead Sciences, Inc.
$13,619
AstraZeneca Pharmaceuticals LP
$8,488
Immunomedics, Inc.
$2,500
Celgene Corporation
$1,333
Rigel Pharmaceuticals, Inc.
$1,025
Seattle Genetics, Inc.
$949
PFIZER INC.
$650
Janssen Biotech, Inc.
$551
Genentech USA, Inc.
$514
Merck Sharp & Dohme LLC
$439
Amgen Inc.
$397
Merck Sharp & Dohme Corporation
$377
Lilly USA, LLC
$301
Incyte Corporation
$287
GENZYME CORPORATION
$255
Kite Pharma, Inc.
$235
Eisai Inc.
$229
Seagen Inc.
$215
Daiichi Sankyo Inc.
$210
Ipsen Biopharmaceuticals, Inc
$186
Astellas Pharma US Inc
$180
Exelixis Inc.
$177
NOVARTIS PHARMACEUTICALS CORPORATION
$167
ABBVIE INC.
$152
Bayer Healthcare Pharmaceuticals Inc.
$150
BeiGene USA, Inc.
$143
Bayer HealthCare Pharmaceuticals Inc.
$143
Foundation Medicine, Inc.
$142
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
EMD Serono, Inc.
$134
TESARO, Inc.
$132
Pharmacosmos Therapeutics Inc.
$102
Puma Biotechnology, Inc.
$101
Takeda Pharmaceuticals U.S.A., Inc.
$99
SANOFI-AVENTIS U.S. LLC
$95
TAIHO ONCOLOGY, INC.
$92
JAZZ PHARMACEUTICALS INC.
$90
GlaxoSmithKline, LLC.
$90
Mirati Therapeutics, Inc.
$82
Regeneron Healthcare Solutions, Inc.
$74
ARRAY BIOPHARMA INC
$68
Janssen Pharmaceuticals, Inc
$62
TerSera Therapeutics LLC
$59
Lexicon Pharmaceuticals, Inc.
$58
EISAI INC.
$57
Heron Therapeutics, Inc.
$57
PharmaEssentia USA Corporation
$57
G1 Therapeutics, Inc.
$52
Clovis Oncology, Inc.
$51
AbbVie, Inc.
$48
Alexion Pharmaceuticals, Inc.
$47
AMAG Pharmaceuticals, Inc.
$41
CSL Behring
$39
MEDIVATION FIELD SOLUTIONS LLC
$39
SOBI, INC
$37
Myriad Genetic Laboratories, Inc.
$33
Secura Bio, Inc.
$32
CTI BioPharma Corp.
$30
Stemline Therapeutics Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$29
Alnylam Pharmaceuticals Inc.
$27
Aurobindo Pharma USA, Inc.
$27
Taiho Oncology, Inc.
$26
Aveo Pharmaceuticals, Inc.
$26
Horizon Therapeutics plc
$26
Agios Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$25
Sun Pharmaceutical Industries Inc.
$24
Adaptive Biotechnologies Corporation
$22
Emmaus Medical, Inc.
$18
Global Blood Therapeutics, Inc.
$18
MorphoSys, US Inc.
$18
EUSA Pharma (US) LLC
$17
Coherus Biosciences Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Abbott Laboratories
$16
Pharmacyclics LLC, An AbbVie Company
$16
Jazz Pharmaceuticals Inc.
$15
Dendreon Pharmaceuticals LLC
$14
Array BioPharma Inc.
$13
SECURA BIO, INC.
$11
Teva Pharmaceuticals USA, Inc.
$11
Veracyte, Inc.
$3
Top 3 companies account for 84.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FASENRA · FERAHEME · FOTIVDA · FOUNDATIONONE · FREESTYLE LIBRE 3 · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
9
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harris is a mixed practice specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harris experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Harris performed 27,400 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $150,121 from 85 companies across 879 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris's costs compare to other hematologists in Daytona Beach?
Dr. Harris's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Daytona Beach
Browse hematologists in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology